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Abstract
For the rapid detection of common aneuploidies either PCR or Fluorescence in situ hybridisation (FISH) on
uncultured amniotic fluid cells are widely used. There are different commercial suppliers providing FISH assays for
the detection of trisomies affecting the Down’s syndrome critical regions (DSCR) in 21q22. We present a case in
which rapid FISH screening with different commercial probes for the DSCR yielded conflicting results. Chromosome
analysis revealed a deletion of one chromosome 21 in q22 which explained the findings. Prenatally an additional
small supernumerary marker chromosome (sSMC) was discovered as well, which could not be characterised.
Postnatal chromosome analysis in lymphocytes of the infant revealed complex mosaicism with four cell lines. By
arrayCGH the sSMC was provisionally described as derivative chromosome 21 which was confirmed by targeted
FISH experiments.
Background
Fluorescence in situ hybridisation (FISH) on uncultured
amniotic fluid cells is a widely used means for the rapid
prenatal diagnosis of common aneuploidies. Different
commercial suppliers provide FISH assays for the detec-
tion of trisomies involving the Down syndrome critical
r e g i o n s( D S C R )i n2 1 q 2 2w h i c hh a v eb e e ne x t e n s i v e l y
validated in single institution series [1,2] and multicenter
trials [3]. Interpretation of FISH results may be difficult if
unexpected results are detected which for example can
be caused by structural aberrations or mosaicism. Here
we present a case in which rapid FISH screening with dif-
ferent commercial probes for the Down’s syndrome criti-
cal regions yielded conflicting results with regard to a
partial monosomy 21q. Moreover, by extensive conven-
tional and molecular karyotyping we show this diagnostic
problem to be caused by a de novo del(21)(q22) as part
o fam o s a i ck a r y o t y p e .D e l e t i o no f2 1 qi sar a r ec h r o m o -
some disorder. In a recent review of 23 patients of whom
reliable mapping data are available the variable pheno-
type depending on the deleted region became obvious
[4]. Intrauterine growth retardation which was the initial
presentation of the proband seems to be a constant
finding.
Results
Case presentation
A 35-year-old woman presented at 24+0 weeks of gesta-
tion of her fourth pregnancy. She had suffered two early
pregnancy losses. The third pregnancy ended in the
delivery of a healthy boy. Medical and family history of
the proposita and her partner were unremarkable. First
trimester-screening including ultrasound and maternal
serum biochemistry had been normal (adjusted risks
+21 = 1:1839; +18 = 1:610; +13 = 1:3515). In the 25
th
week, ultrasound revealed symmetric foetal retardation
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corpus callosum, short nasal bone and hyperechogenic
bowel. Therefore, amniocentesis was performed and foe-
tal karyotyping initiated. For rapid screening for aneu-
ploidies, FISH was performed according to standard
methods on uncultured amniotic cells using a commer-
cially available probe set (Abbott, Wiesbaden). Signal
patterns indicated a normal female gonosome constella-
tion without evidence for aneuploidies detectable with
the probes for chromosomes 13 and 18. Nevertheless,
the approximately 200 kb-sized LSI21 probe for the
DSCR1 containing the loci D21S529, D21S341 and
D21S342 in 21q22 showed only one signal in 97 of 100
(97%) evaluated nuclei. To corroborate these findings by
an independent probe, FISH was performed with a dif-
ferent commercial probe, PN21 (Kreatech, Berlin). This
probe containing the markers D21S65, RH72110 and
RH92717 and hybridising to DSCR4 and 8, revealed a
normal pattern with two signals in the majority (86/100)
of the nuclei, whereas a minority (14%) lacked one sig-
nal. Additional FISH analyses on uncultured amniotic
cells with PAC probes for 21q11.2~21 (RP1-270M7 and
RP1-152M24) as well as a commercial probe (Abbott,
Wiesbaden) for the AML1 locus in 21q22 yielded a nor-
mal signal pattern. Mapping of both commercial probes
indicated that they both hybridise approximately 3,3 Mb
apart with the Abbott probe being located telomeric of
the Kreatech probe (see Fig. 1). Therefore, the FISH pat-
terns were judged as indicative for a de novo deletion in
21q with the breakpoint between the regions the two
probes hybridise to. This interpretation was confirmed
by the results of chromosome banding analysis of
15 metaphases from two independent cultures. All
metaphases analysed showed a terminal deletion of the
long arm of chromosome 21 with the breakpoint in
21q22. Moreover, in all metaphases an additional small
marker chromosome (sSMC) was detected, of which the
origin could not be identified using DA/DAPI staining
and various FISH probes. The karyotype was described
as 47, XX, del(21)(q22),+mar[15]. Chromosome analysis
in the parents including FISH with chromosome 21 spe-
cific probes revealed a normal female respectively male
karyotype in 10 metaphases analysed.
The couple was extensively counselled on the results
and the pregnancy was continued. The pregnancy was
monitored regularly by ultrasound. Foetal growth
restriction was obvious onward. By the end of the preg-
nancy the patient revealed clinical signs of preeclampsia
so that birth was induced at 41+2 weeks of gestation.
The child was born at 41+3 weeks with a length of
46 cm (-2.74 SD), weight of 2240 g (-4.4 SD), and a
head circumference of 31 cm (-3.16 SD). APGAR scores
were 1/8/9. On examination a high nasal root, down-
slanting palpebral fissures, retrogenia, posterior rotated,
slightly low-set ears, a long philtrum, and a thin upper
vermillion were noticed. The fingernails were small.
A sacral dimple was observed. Ultrasound of the abdo-
men gave inconspicuous results. Echocardiography
showed a patent ductus artiosus Botalli (PDA) and atrial
septal defect (ASD) without hemodynamic consequence.
Cerebral ultrasound showed a missing septum pelluci-
dum. The infant had a good muscle tone. The major
problem was the feeding, most probably due to sucking
weakness and a lack of coordination so that a feeding
tube had to be placed.
To confirm the prenatal findings and further character-
ise the chromosomal changes DNA was extracted from
cord-blood taken at birth and subjected to molecular
karyotyping using two different platforms. Array CGH was
performed using the Human Genome CGH Microarray
244A platform (Agilent Technologies, Santa Clara, USA).
Moreover, hybridization to Cyto2.7 arrays (Affymetrix,
Santa Clara, CA, USA) was performed. Both array plat-
forms confirmed the presence of a most likely telomeric
deletion with the breakpoint in 21q22 at around chr21:
37,381,170 bp (Agilent 244A) and 37,302,549 bp (Cyto2.7
Affymetrix), both mapped according to NCBI Build 36.
The molecular karyotyping results explained the discre-
pant results with the commercial FISH probes PN21 from
Kreatech (~34,538,500-35,086,000 bp) and LSI 21 from
Abbott (~38,353,445-38,553,733 bp) for 21q, which hybri-
dise centromeric and telomeric of the breakpoint, respec-
tively. Nevertheless, in addition both array platforms
p r o v i d ea l s oe v i d e n c ef o ra deletion of 21q11.2q22.13
(14,319,839-37,381,170 bp) in a subset of cells as indicated
by the decrease of the signal intensity to around -0.5 as
typical for mosaicism of a loss. Therefore, we performed
chromosome banding analysis on a peripheral blood sam-
ple of the child which indeed yielded evidence for the pre-
sence of four cell lines differing by the presence and
absence of the del(21) and the sSMC. The karyotype was
described as: mos 47, XX, del(21)(q22),+mar[22]/46, XX,
del(21)(q22)[7]/46, XX, -21, +mar[5]/45, XX, -21[4]. The
complete loss of chromosome 21 in 9 of 38 metaphases
explains the decreased copy number in 21q11.2q22.13 in
the array analyses and is also in line with the prenatal
FISH analyses indicating loss of 21q21~22 including
DSCR4/8 in 14% of nuclei. The lack of an imbalance at
the very centromeric part of 21q in the array analyses
along with the absence of larger copy number gains on
other chromosomes suggests, that the sSMC is derived
from chromosome 21 and represents a del(21)(q11.2). To
confirm this view, FISH was performed with a probe (PAC
1174A5) for the rRNA gene cluster which yielded a signal
on the sSMC [5]. A weak signal was observed with a
whole chromosome painting probe for chromosome 21
(Kreatech, Berlin). Hybridization with a probe detecting
the centromeres of chromosomes 13 and 21 (Kreatech,
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findings render the interpretation that the sSMC, is a del
(21)(q11.2) likely.
Discussion
In summary we report on a case with pre- and postnatal
findings of partial monosomy 21q22 and mosaicism for
the loss of the normal chromosome 21. With a commer-
cial FISH probe binding distal to the breakpoint this
gave a pattern suggestive of monosomy, whereas with a
second probe binding proximal to the breakpoint the
distribution of the signals was normal. Part of the com-
plex mosaicism could have been suspected by the find-
ings obtained on uncultivated amniotic cells with a
probe binding proximal to the breakpoint in 21q22, but
it was missed on the cultured amniotic cells. As no
fibroblasts of the patient were analysed it cannot be
ruled out that the complex mosaicism arose as a postzy-
gotic error in blood lymphocytes.
In about 0,075% of prenatal cases an sSMC is detected
[6]. Like in this case it is not always possible to charac-
terise the sSMC on the prenatal sample due to lack of
material. As the main aberration is the deletion 21q22
terminal of 37,3 Mb. The patient’s deletion is similar to
those described by Matsumoto et al and Yao et al [7,8]
(patient 1) and Lyle et al. [9] (patient 35). The spectrum
of patients with 21q deletions is wide. Lindstrand et al.
[4] described three new patients and reviewed 38
patients in the literature and databases. For 20 patients
reliable data of molecular or molecular cytogenetic
investigations were available. According to their findings
deletions involving a 0,56 Mb region between 34,796
and 35,363 kb (from pter) are associated with severe
heart disease. This is in line with our findings as the
Figure 1 Mapping of commercial probes. A: Partial karyotype of the infant with del(21)(q22) and supernumerary marker chromosome. B:
fluorescence-in-situ-hybridization with probes for the Down-syndrome critical regions (B1: Kreatech, B2: Abbott) showing conflicting results. C:
The array profile confirms the del(21)(q22) as well as the mosaicism for the derivative chromosome 21 and the supernumerary marker
chromosome originating from chromosome 21.
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hemodynamic relevance. The region for mental retarda-
tion was narrowed down to 33,833 - 33,992 kb. The
observation time in our patient is too short for any con-
clusions. Intrauterine growth retardation (IUGR) seems
to be a constant symptom. Chromosome analysis on the
patient’s lymphocytes revealed a cell line with monos-
omy for chromosome 21. In retrospect this cell line was
also present in uncultured amniotic fluid cells, therefore
it represents most likely true mosaicism. Full monosomy
21 (FM21) is a rare finding and probably incompatible
with life (for review see [10]). We are only aware of one
live-born patient with FM21 in whom the monosomy
was proven by molecular cytogenetic methods in various
tissues [11]. FM21 is characterised by severe IUGR,
brain malformations (holoprosencephaly, polymicro-
gyria), facial dysmorphism, heart defects, and severe
ocular malformations. There are patients in whom
mosaicism for a cell line with monosomy 21 and a sec-
ond cell line for example with trisomy 21 was detected
[12]. In those patients the symptoms of monosomy 21
dominated over those of trisomy 21. The proband does
not have any of the severe malformations of FM21.
There is some overlap in the symptoms of partial and
full monosomy 21. As the percentage of cells with
monosomy 21 was comparatively low in the proband
this cell line did not have a detrimental effect.
Conclusions
FISH on uncultivated amniotic cells with commercial
probes is a widespread method to detect aneuploidies in
prenatal diagnosis. Caution has to be warranted with
regard to the interpretation of FISH patterns from pre-
natal screening if they do not represent the typical signal
patterns. In order to interpret the results knowledge as
to the precise localisation of the clones and hybridiza-
tion with additional probe sm a yb en e c e s s a r y .I nm o s t
cases the result of FISH on uncultivated amniotic cells
is in line with that of the chromosome banding analysis.
However, this case highlights that structural aberrations
and mosaicism can lead to results which are difficult to
interpret. In general FISH for five chromosomes does
not rule out numerical aberrations of all other chromo-
somes, structural aberrations, and sSMCs. False-positive
respectively false negative results are also possible due
to dicentric chromosomes, centromeric polymorphism,
and maternal contamination [13]. FISH on uncultured
cells has to be supplemented by conventional banding
analysis. ArrayCGH is a powerful tool in the precise
delineation of the structural aberration. Detection of
mosaicism is possible but complex mosaicism is better
characterised by techniques based on the evaluation of
single cells.
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